Medigen Biotechnology Free Cash Flow Generation Index
Medigen Biotechnology free cash flow generation index. Medigen Biotechnology (3176) has a Free Cash Flow Generation Index of 0.94x as of December 2024. Free cash flow of NT$147.66 Million represents 1% of operating cash flow (NT$156.75 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Medigen Biotechnology (2003–2024)
Free cash flow generation index of Medigen Biotechnology from 2003 to 2024. Historical FCF Generation Index trend for Medigen Biotechnology across 5 annual periods. See 3176 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Medigen Biotechnology Free Cash Flow Generation Index by Year (2003–2024)
Medigen Biotechnology free cash flow generation index by year from 2003 to 2024. Year-by-year Free Cash Flow Generation Index for Medigen Biotechnology. For the full cash flow conversion analysis, see cash flow conversion of Medigen Biotechnology.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | NT$-20.76 Million | NT$37.92 Million | NT$58.68 Million | ▼ -176.0% |
| 2021 | 0.72x | NT$372.90 Million | NT$517.45 Million | NT$144.55 Million | ▼ -73.8% |
| 2015 | 2.75x | NT$809.42 Million | NT$294.18 Million | NT$515.25 Million | ▲ +164.6% |
| 2005 | 1.04x | NT$83.93 Million | NT$80.72 Million | NT$3.21 Million | ▲ +3.1% |
| 2003 | 1.01x | NT$449.42 Million | NT$445.46 Million | NT$3.96 Million | — |